July 9, 2013: by longevinex.com
Las Vegas, NV (July 9, 2013) – In an effort to help ensure its product is not removed from the marketplace by onerous requirements stipulated by regulatory agencies or by covert efforts to undermine its product quality, Longevinex® announces today its proprietary red wine anti-aging capsules have passed stringent sub-acute toxicity testing, a requirement for further human testing.
Longevinex® red wine capsules did not produce significant toxic side effects or mortality in laboratory mice at human equivalent doses of 3500 and 7000 milligrams per day (~10-20 oral capsules/day) in testing conducted under the supervision of Hannah R. Vasanthi PhD, at the Department of Biotechnology, Pondicherry University, India. A complete report was published in the journal of Food & Chemical Toxicology.
May 27, 2013: by longevinex.com
Las Vegas, NV (May 27, 2013) – Longevinex® (long-jev-in-ex), maker of the leading red-wine longevity pill, has added the stress relieving amino acid theanine to its patent-applied-for 5th-generation Longevinex Advantage® formula to address the stressful challenges of modern living.
“In this aging-is-optional era, advances in biology now indicate the clock hands of biological time can be reversed at the cellular level, but strikingly we find psychological stress can over-ride the beneficial effects of so-called anti-aging pills,” says Bill Sardi, originator of Longevinex®.
“Newly-understood science points to elevated adrenal stress hormones that are linked to unhealthy aging — particularly in the brain and other organs. So it now becomes important to provide a safe and effective ingredient in Longevinex Advantage® that addresses stress and anxiety, a growing problem in our modern society,” Sardi says
March 13, 2013: by Bill Sardi
…. mice fed a normal-calorie diet did not live longer, the initial experiment to show the primary gene target for resveratrol was flawed and a huge dose of this red wine molecule barely improved measurable health parameters among metabolic disease (diabetes) patients and induced kidney failure among terminal cancer patients, causing the sponsor of a resveratrol-based drug to halt all research and development.
March 10, 2013: by longevinex.com
The dose of natural molecules provided in Longevinex® has been carefully determined to achieve optimal biological effect. Excessive dose of Longevinex® or other molecules in the diet or food supplements similar to those provided in Longevinex® (bioflavonoids and polyphenols- list provided below) may be counterproductive and dull or negate the optimal health benefits that Longevinex® is designed to achieve.
December 12, 2012: by Bill Sardi
MicroRNA studies conducted at the National Institutes of Health reveal one particular brand of resveratrol-based pill, Longevinex®, exhibits a distinctive gene activity pattern apart from plain resveratrol. In particular, Longevinex strongly inhibits production of gene proteins produced when tissues are deprived of oxygen and subsequently develop new abnormal blood vessels in an attempt to deliver O2 to tissues.
In the study published in PLoS ONE, just two microRNA represented over 90% of Longevinex’ broad gene activity. (Micro RNA are small RNA molecules that regulate gene activity.)
July 30, 2008: by longevinex.com
– Independent Laboratory Animal Study
San Dimas, CA · July 30, 2008 /PRNewswire/ – Researchers report that a proprietary nutraceutical matrix (Longevinex®) exhibits striking effects upon genes controlling energy metabolism, nine times broader than research-grade resveratrol and calorie restriction (mouse study- Experimental Gerontology, early online edition, July 2008, for August hard-bound edition) at doses of resveratrol 17-320 fold lower than used in previous animal studies.